Clinical Trial Update: Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of pregabalin for pain on walking in diabetic peripheral neuropathy; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Diabetic Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2014-11-18